Cytori Therapeutics reported $3.93M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Cytori Therapeutics CYTX:US $ 3.93M 13K
Dr.Reddys Laboratories DRRD:IN 44.17B 3.04B
Genocea Biosciences GNCA:US $ 16.04M 118.06M
Mirati Therapeutics MRTX:US $ 184.93M 12.45M
Northwest Biotherapeutics NWBO:US 10.7M 298K
Sun Pharmaceuticals SUNP:IN IR 77998.2M 3498.1M
Teva Pharmaceutical TEVA:IT 4.02B 758M